1.
Okamura K, Matsushima M, Takamiya Y, Okuda T, Sako H, Udo A, et al. Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity. J Clin Med Res [Internet]. 2024 Jan. 1 [cited 2025 Dec. 26];16(10):509-17. Available from: https://jocmr.elmerjournals.com/jocmr/article/view/6058